Biomarker
|
|
|
|
AMP-activated protein kinase conducts the ischemic stress response orchestra
Circulation (2008) 117; 832-40
L. H. Young |
|
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
Eur Heart J (2008)
K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz and V. Krane |
|
Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?
Heart (2008) 94; 679-84
H. D. White |
|
dentifying the vulnerable patient with rupture-prone plaque
Am J Cardiol (2008) 101; 3F-10F
H. S. Weintraub |
|
Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study
J Am Coll Cardiol (2008) 51; 1196-202
M. F. Walter, R. F. Jacob, R. E. Bjork, B. Jeffers, J. Buch, Y. Mizuno and R. P. Mason |
|
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
Eur Heart J (2009)
A. A. Voors, S. von Haehling, S. D. Anker, H. L. Hillege, J. Struck, O. Hartmann, A. Bergmann, I. Squire, D. J. van Veldhuisen and K. Dickstein |
|
Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study
Circulation (2008) 117; 1138-44
R. S. Vasan, S. Demissie, M. Kimura, L. A. Cupples, N. Rifai, C. White, T. J. Wang, J. P. Gardner, X. Cao, E. J. Benjamin, D. Levy and A. Aviv |
|
Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome
Am J Cardiol (2008) 102; 135-9
M. G. van Oijen, B. E. Claessen, N. Clappers, A. van Schaik, R. J. Laheij, J. B. Jansen, W. H. Peters and F. W. Verheugt |
|
Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty
Am J Cardiol (2008) 101; 753-7
D. Tzivoni, D. Koukoui, V. Guetta, L. Novack and G. Cowing |
|
Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome
Eur Heart J (2008) 29; 2713-22
D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski and H. Boudoulas |
|
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery
Am J Cardiol (2008) 102; 1608-13
K. Tsujita, A. Maehara, G. S. Mintz, H. Doi, T. Kubo, C. Castellanos, J. Liu, J. Yang, C. Oviedo, T. Franklin-Bond, N. Dasgupta, S. Biro, L. Dani, G. D. Dangas, R. Mehran, A. J. Kirtane, A. J. Lansky, E. M. Kreps, M. B. Collins, G. W. Stone, J. W. Moses and M. B. Leon |
|
Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration
Am J Cardiol (2009) 103; 29-35
C. J. Terkelsen, C. Oxvig, B. L. Norgaard, S. Glerup, T. S. Poulsen, J. F. Lassen, H. J. Moller, L. Thuesen, E. Falk, T. T. Nielsen and H. R. Andersen |
|
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome
Am J Cardiol (2008) 102; 653-7
U. U. Tamhane, S. Aneja, D. Montgomery, E. K. Rogers, K. A. Eagle and H. S. Gurm |
|
Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome
Am J Cardiol (2008) 102; 509-12
R. Stein, B. Gupta, S. Agarwal, J. Golub, D. Bhutani, A. Rosman and C. Eng |
|
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease
Am Heart J (2008) 155; 356-60
A. Stefanescu, S. Braun, G. Ndrepepa, T. Koppara, H. Pavaci, J. Mehilli, A. Schomig and A. Kastrati |
|
Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation
Heart (2008) 94; 311-5
J. Sanchis, X. Bosch, V. Bodi, N. Bellera, J. Nunez, B. Benito, J. Ordonez, L. Consuegra, M. Heras and A. Llecer |
|
Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years
Am J Cardiol (2008) 102; 218-22
A. Sahlen, R. Winter, B. Lind, P. H. Jacobsen, M. Stahlberg, T. Marklund, T. Fux, J. Svensson and F. Braunschweig |
|
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Circulation (2008) 117; 1936-44
M. S. Sabatine, D. A. Morrow, L. J. Higgins, C. MacGillivray, W. Guo, C. Bode, N. Rifai, C. P. Cannon, R. E. Gerszten and R. T. Lee |
|
The measurement of plasma aldosterone in patients post-myocardial infarction
Eur Heart J (2008) 29; 2451-2
B. Pitt |
|
Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction
Eur Heart J (2008) 29; 2489-96
B. R. Palmer, A. P. Pilbrow, C. M. Frampton, T. G. Yandle, L. Skelton, M. G. Nicholls and A. M. Richards |
|
Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome
Am J Cardiol (2008) 101; 1-7
H. Otake, J. Shite, T. Shinke, S. Watanabe, Y. Tanino, D. Ogasawara, T. Sawada, K. Hirata and M. Yokoyama |
|
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J (2009)
S. Orn, C. Manhenke, T. Ueland, J. K. Damas, T. E. Mollnes, T. Edvardsen, P. Aukrust and K. Dickstein |
|
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
J Am Coll Cardiol (2008) 51; 627-33
T. Omland, T. Ueland, A. M. Jansson, A. Persson, T. Karlsson, C. Smith, J. Herlitz, P. Aukrust, M. Hartford and K. Caidahl |
|
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction
Am J Cardiol (2008) 101; 747-52
J. Nunez, E. Nunez, V. Bodi, J. Sanchis, G. Minana, L. Mainar, E. Santas, P. Merlos, E. Rumiz, H. Darmofal, A. M. Heatta and A. Llacer |
|
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Am Heart J (2008) 155; 673-9
M. B. Nienhuis, J. P. Ottervanger, M. J. de Boer, J. H. Dambrink, J. C. Hoorntje, A. T. Gosselink, H. Suryapranata and A. W. van't Hof |
|
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention
Eur Heart J (2008) 29; 1843-50
G. Niccoli, S. Giubilato, E. Russo, C. Spaziani, A. Leo, I. Porto, A. M. Leone, F. Burzotta, S. Riondino, F. Pulcinelli, L. M. Biasucci and F. Crea |
|
Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry)
Am J Cardiol (2009) 103; 583-7
C. K. Naber, R. H. Mehta, C. Junger, U. Zeymer, H. Wienbergen, G. V. Sabin, R. Erbel, J. Senges and A. Gitt |
|
Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease
Am J Cardiol (2008) 102; 54-7
P. Muntner, D. Mann, J. Winston, S. Bansilal and M. E. Farkouh |
|
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
Eur Heart J (2008) 29; 1096-102
D. A. Morrow, M. S. Sabatine, M. L. Brennan, J. A. de Lemos, S. A. Murphy, C. T. Ruff, N. Rifai, C. P. Cannon and S. L. Hazen |
|
Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina
Heart (2008) 94; 1002-7
S. Miyamoto, M. Ueda, M. Ikemoto, T. Naruko, A. Itoh, S. Tamaki, R. Nohara, F. Terasaki, S. Sasayama and M. Fujita |
|
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale
Am Heart J (2008) 155; 600-8
R. H. Mehta, J. H. Alexander, R. Emery, S. J. Ellis, V. Hasselblad, A. Khalil, M. Carrier, R. A. Harrington and J. C. Tardif |
|
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Lancet (2008) 372; 224-33
M. J. McQueen, S. Hawken, X. Wang, S. Ounpuu, A. Sniderman, J. Probstfield, K. Steyn, J. E. Sanderson, M. Hasani, E. Volkova, K. Kazmi and S. Yusuf |
|
Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain
Am J Cardiol (2009) 103; 22-8
C. J. McCann, B. M. Glover, I. B. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young and J. A. Adgey |
|
Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin
Eur Heart J (2008) 29; 2843-50
T C. J. McCann, B. M. Glover, I. B. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young and J. A. Adgey |
|
In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction
Eur Heart J (2008) 29; 2201
M. R. Makowski, U. Ebersberger, S. Nekolla and M. Schwaiger |
|
Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease
Am J Cardiol (2009) 103; 476-81
Y. Liu, X. Li, D. Peng, Z. Tan, H. Liu, Y. Qing, Y. Xue and G. P. Shi |
|
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes
Am Heart J (2008) 155; 718-24
K. D. Lim, A. T. Yan, A. Casanova, R. T. Yan, A. Mendelsohn, S. Jolly, D. H. Fitchett, A. Langer and S. G. Goodman |
|
DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study
Eur Heart J (2008) 29; 1250-8
M. Kolz, W. Koenig, M. Muller, M. Andreani, S. Greven, T. Illig, N. Khuseyinova, D. Panagiotakos, G. Pershagen, V. Salomaa, J. Sunyer and A. Peters |
|
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Eur Heart J (2009)
S. Q. Khan, K. Ng, O. Dhillon, D. Kelly, P. Quinn, I. B. Squire, J. E. Davies and L. L. Ng |
|
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Eur Heart J (2008) 29; 1485-94
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa and M. Kurabayashi |
|
Prognostic value of circulating chromogranin A levels in acute coronary syndromes
Eur Heart J (2009) 30; 25-32
A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg and K. Caidahl |
|
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention
Am J Cardiol (2009) 103; 779-84
A. K. Hassan, S. C. Bergheanu, H. Hasan-Ali, S. S. Liem, A. van der Laarse, R. Wolterbeek, D. E. Atsma, M. J. Schalij and J. W. Jukema |
|
Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease
J Am Coll Cardiol (2008) 52; 1803-9
T. J. Guzik, W. Chen, M. C. Gongora, B. Guzik, H. E. Lob, D. Mangalat, N. Hoch, S. Dikalov, P. Rudzinski, B. Kapelak, J. Sadowski and D. G. Harrison |
|
The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatment
Eur Heart J (2008) 29; 2827-8
J. Gravning and J. Kjekshus |
|
Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study
Eur Heart J (2008) 29; 1966-74
J. P. Empana, F. Canoui-Poitrine, G. Luc, I. Juhan-Vague, P. Morange, D. Arveiler, J. Ferrieres, P. Amouyel, A. Bingham, M. Montaye, J. B. Ruidavets, B. Haas, A. Evans and P. Ducimetiere |
|
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome
Am Heart J (2008) 156; 588-94
K. M. Eggers, B. Lagerqvist, J. Oldgren, P. Venge, L. Wallentin and B. Lindahl |
|
Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock
Am J Cardiol (2008) 101; 1537-40
A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez and J. C. Kaski |
|
Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery
Am J Cardiol (2009) 103; 639-45
A. De Labriolle, G. Lemesle, L. Bonello, A. I. Syed, S. D. Collins, I. Ben-Dor, T. L. Pinto Slottow, Z. Xue, R. Torguson, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard, J. Lindsay and R. Waksman |
|
Results of the Predictors of Response to CRT (PROSPECT) trial
Circulation (2008) 117; 2608-16
E. S. Chung, A. R. Leon, L. Tavazzi, J. P. Sun, P. Nihoyannopoulos, J. Merlino, W. T. Abraham, S. Ghio, C. Leclercq, J. J. Bax, C. M. Yu, J. Gorcsan, 3rd, M. St John Sutton, J. De Sutter and J. Murillo |
|
Decreased activated protein C levels as a clinical predictor in patients with ST-elevation myocardial infarction
Am Heart J (2008) 156; 931-8
N. Chiba, K. Nagao, T. Mukoyama, Y. Tominaga and K. Tanjoh |
|
Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling
Eur Heart J (2008) 29; 1608-17
J. Chan, F. Khafagi, A. A. Young, B. R. Cowan, C. Thompson and T. H. Marwick |
|
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study
J Am Coll Cardiol (2008) 51; 2339-46
P. Bogaty, L. Boyer, S. Simard, F. Dauwe, R. Dupuis, B. Verret, T. Huynh, F. Bertrand, G. R. Dagenais and J. M. Brophy |
|
Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome
Am Heart J (2008) 156; 193-200
B. Bigalke, T. Geisler, K. Stellos, H. Langer, K. Daub, E. Kremmer, P. Seizer, A. E. May, S. Lindemann and M. Gawaz |
|
Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
Eur Heart J (2008) 29; 1819-26
F. Baldazzi, E. Jorgensen, R. S. Ripa and J. Kastrup |
|
A comparison between B-type natriuretic peptide, global registry of acute coronary events (GRACE) score and their combination in ACS risk stratification
Heart (2009)
D. S. Ang, L. Wei, M. P. Kao, C. C. Lang and A. D. Struthers |
|
|
|
|
|
|
|